TWD 51.2
(-8.24%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 439.88 Million TWD | 139.03% |
2022 | 184.03 Million TWD | -21.34% |
2021 | 233.96 Million TWD | 22.87% |
2020 | 190.4 Million TWD | 47.28% |
2019 | 129.28 Million TWD | 147.92% |
2018 | 52.14 Million TWD | -14.52% |
2017 | 61 Million TWD | -12.68% |
2016 | 69.86 Million TWD | 0.0% |
2015 | - TWD | 0.0% |
2014 | - TWD | 0.0% |
2013 | - TWD | 0.0% |
2012 | - TWD | 0.0% |
2011 | - TWD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q1 | 23.33 Million TWD | 66.66% |
2024 Q2 | 33.75 Million TWD | 44.64% |
2023 Q1 | 176.07 Million TWD | -4.33% |
2023 FY | 439.88 Million TWD | 139.03% |
2023 Q2 | 174.46 Million TWD | -0.91% |
2023 Q3 | 455.54 Million TWD | 161.11% |
2023 Q4 | 439.88 Million TWD | -3.44% |
2022 FY | 184.03 Million TWD | -21.34% |
2022 Q4 | 184.03 Million TWD | -5.8% |
2022 Q3 | 195.36 Million TWD | -5.57% |
2022 Q2 | 206.89 Million TWD | -6.38% |
2022 Q1 | 220.98 Million TWD | -5.55% |
2021 Q2 | 225.68 Million TWD | 22.9% |
2021 Q1 | 183.63 Million TWD | -3.56% |
2021 Q4 | 233.96 Million TWD | -5.4% |
2021 Q3 | 247.31 Million TWD | 9.58% |
2021 FY | 233.96 Million TWD | 22.87% |
2020 Q1 | 126.78 Million TWD | -1.93% |
2020 Q2 | 114.65 Million TWD | -9.57% |
2020 Q3 | 104.53 Million TWD | -8.83% |
2020 Q4 | 190.4 Million TWD | 82.15% |
2020 FY | 190.4 Million TWD | 47.28% |
2019 Q2 | 139.68 Million TWD | -4.77% |
2019 FY | 129.28 Million TWD | 147.92% |
2019 Q4 | 129.28 Million TWD | -0.65% |
2019 Q3 | 130.13 Million TWD | -6.84% |
2019 Q1 | 146.67 Million TWD | 181.28% |
2018 FY | 52.14 Million TWD | -14.52% |
2018 Q1 | 58.78 Million TWD | -3.63% |
2018 Q4 | 52.14 Million TWD | -4.07% |
2018 Q3 | 54.36 Million TWD | -3.91% |
2018 Q2 | 56.57 Million TWD | -3.77% |
2017 FY | 61 Million TWD | -12.68% |
2017 Q4 | 61 Million TWD | -3.5% |
2017 Q3 | 63.21 Million TWD | -3.39% |
2017 Q2 | 65.43 Million TWD | -3.27% |
2017 Q1 | 67.64 Million TWD | -3.17% |
2016 Q2 | - TWD | 0.0% |
2016 Q4 | 69.86 Million TWD | 0.0% |
2016 Q3 | - TWD | 0.0% |
2016 FY | 69.86 Million TWD | 0.0% |
2016 Q1 | - TWD | 0.0% |
2015 Q3 | - TWD | 0.0% |
2015 Q4 | - TWD | 0.0% |
2015 Q2 | - TWD | 0.0% |
2015 Q1 | - TWD | 0.0% |
2015 FY | - TWD | 0.0% |
2014 Q1 | - TWD | 0.0% |
2014 FY | - TWD | 0.0% |
2014 Q4 | - TWD | 0.0% |
2014 Q3 | - TWD | 0.0% |
2014 Q2 | - TWD | 0.0% |
2013 Q2 | - TWD | 0.0% |
2013 FY | - TWD | 0.0% |
2013 Q1 | - TWD | 0.0% |
2013 Q4 | - TWD | 0.0% |
2012 Q3 | - TWD | 0.0% |
2012 Q4 | - TWD | 0.0% |
2012 FY | - TWD | 0.0% |
2011 FY | - TWD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
SYN-TECH Chem. & Pharm. Co., Ltd. | 60.65 Million TWD | -625.265% |
Level Biotechnology Inc. | 9.88 Million TWD | -4350.056% |
Sagittarius Life Science Corp | 6.25 Million TWD | -6933.706% |
NeoCore Technology Co., Ltd. | 33.65 Million TWD | -1207.167% |
TaiMed Biologics Inc. | 521.7 Million TWD | 15.683% |
GlycoNex Incorporation | - TWD | -Infinity% |
VBI | - TWD | -Infinity% |
GeneReach Biotechnology Corp. | 97.74 Million TWD | -350.05% |
Taiwan Advance Bio-Pharmaceutical Inc. | 86.89 Million TWD | -406.258% |
Visgeneer Inc. | 114.17 Million TWD | -285.282% |
Mycenax Biotech Inc. | 569.78 Million TWD | 22.798% |
Sunmax Biotechnology Co., Ltd. | 144.77 Million TWD | -203.843% |
G&E Herbal Biotechnology Co., Ltd. | 1.29 Million TWD | -33894.436% |
Medigen Vaccine Biologics Corporation | 254.35 Million TWD | -72.942% |
TaiwanJ Pharmaceuticals Co., Ltd. | 472 Thousand TWD | -93096.61% |
Enimmune corporation | 1.75 Million TWD | -24907.845% |
TaiRx, Inc. | 8.96 Million TWD | -4804.538% |
CHO Pharma, Inc. | - TWD | -Infinity% |
EirGenix Inc. | 436.54 Million TWD | -0.766% |
BioLASCO Taiwan Co., Ltd. | 51.43 Million TWD | -755.264% |
Sunny Pharmtech Inc. | 376.29 Million TWD | -16.899% |
Lin BioScience, Inc. | 29.02 Million TWD | -1415.496% |
BioGend Therapeutics Co., Ltd. | 9.44 Million TWD | -4559.337% |
Feng Chi Biotech Corp. | 8.14 Million TWD | -5298.061% |
Bio Preventive Medicine Corp. | 106.2 Million TWD | -314.207% |
Lukas Biomedical Inc. | 69.9 Million TWD | -529.265% |
RBC Bioscience Corporation | 412.59 Million TWD | -6.614% |
BiOptic Inc. | 85.79 Million TWD | -412.738% |
BRIM Biotechnology, Inc. | 108 Thousand TWD | -407203.704% |
Shine-On BioMedical Co.,Ltd. | - TWD | -Infinity% |
Great Novel Therapeutics Biotech & Medicals | 10.88 Million TWD | -3942.717% |
Syngen Biotech Co.,Ltd. | 386.07 Million TWD | -13.938% |
Anti-Microbial Savior BioteQ Co., Ltd | - TWD | -Infinity% |
SynCore Biotechnology Co.,Ltd | - TWD | -Infinity% |
Genomics BioSci & Tech. Co.,Ltd. | 222.24 Million TWD | -97.93% |
Neith Corporation | 714 Thousand TWD | -61508.964% |
Advagene Biopharma Co., Ltd. | - TWD | -Infinity% |
NaviFUS Corp. | 25.83 Million TWD | -1602.551% |
Gwo Xi Stem Cell Applied Technology Co. , Ltd | 366 Million TWD | -20.186% |
Sinew Pharma Inc. | - TWD | -Infinity% |
Andros Pharmaceuticals Co.,Ltd | 22.02 Million TWD | -1897.312% |
Greenyn Biotechnology Co., Ltd | 55.91 Million TWD | -686.68% |
Lumosa Therapeutics Co., Ltd. | 8.11 Million TWD | -5319.342% |
AP Biosciences Inc | 70.42 Million TWD | -524.601% |
Medigen Biotechnology Corp. | 449.09 Million TWD | 2.051% |
3D Global Biotech Inc. | 4.08 Million TWD | -10676.286% |
Pharmosa Biopharm Inc. | 118.41 Million TWD | -271.48% |
Intech Biopharm Corporation | 970.4 Million TWD | 54.67% |
Oneness Biotech Co., Ltd. | 397.95 Million TWD | -10.539% |
Eusol Biotech Co.,Ltd. | 1.6 Million TWD | -27290.286% |
TWi Biotechnology, Inc. | 5.6 Million TWD | -7750.937% |
Ever Supreme Bio Technology Co., Ltd | 503 Thousand TWD | -87352.883% |
TCI GENE Inc. | - TWD | -Infinity% |
MegaPro Biomedical Co., Ltd | 5.62 Million TWD | -7716.063% |
Senhwa Biosciences, Inc. | 3.28 Million TWD | -13282.659% |
Taiwan Bio Therapeutics Co., Ltd | 250.51 Million TWD | -75.595% |
NatureWise Biotech & Medicals Corporation | 3.26 Million TWD | -13372.833% |
PharmaEngine, Inc. | 7.14 Million TWD | -6058.309% |
Savior Lifetec Corporation | 257.03 Million TWD | -71.137% |
TaiGen Biopharmaceuticals Holdings Limited | 58.71 Million TWD | -649.256% |
Meribank Biotech Co., Ltd | 14.81 Million TWD | -2870.009% |
Acepodia, Inc. | 233.45 Million TWD | -88.429% |
Caliway Biopharmaceuticals Co., Ltd. | 11.87 Million TWD | -3604.632% |